6 August 2020
Scrip Dividend Price
Celtic plc confirms that the scrip dividend reference price for the full year dividend for the financial year ended 30 June 2020, is 115p ("Scrip Reference Price") and will be payable on 28 August 2020. The scrip dividend is available to any shareholders of Celtic plc's Convertible Cumulative Preference Shares of 60p each who have elected to receive ordinary shares of 1p each in the Company ("Ordinary Shares") in lieu of cash dividends through participation in the Scrip Dividend Scheme.
The Scrip Reference Price has been calculated by taking the average middle market quotation price of Celtic plc's Ordinary Shares derived from the London Stock Exchange Daily Official List for the day on which the shares were first quoted as ex-dividend (30 July 2020) and the four subsequent dealing days (being 31 July, 3 August, 4 August and 5 August 2020).
Any shareholders entitled to the full year dividend who do not already participate in the Scrip Dividend Scheme and wish to do so, may obtain a mandate form by contacting the Company's Registrar, Computershare on 0370 702 0192 or from the Company's website www.celticfc.net, or from the National Storage Mechanism. This form must be completed and returned to Computershare to arrive no later than the close of business on 10 August 2020 in order for it to be effective for the full year dividend.
The exact number of shares which will require to be issued will be established after 10 August 2020 the final date for receipt of elections to participate in the Scrip Dividend Scheme.
Scrip dividend timetable for the final dividend for the year ended 30 June 2020
30 July 2020
31 July 2020
Scrip reference price calculation period
30 July - 5 August 2020
Last date for receipt of Scrip elections
10 August 2020
Dividend payment/Scrip issue date
28 August 2020
Michael Nicholson, Company Secretary 0141 551 4298
Canaccord Genuity Limited
Simon Bridges, Nominated Adviser 0207 523 8350
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visit www.rns.com.